Exact Sciences believes that everyone should have access to the information they need to make confident, informed decisions about their cancer treatments. That’s why Exact Sciences created the Genomic Access Program (GAP), which helps eligible patients navigate insurance and other payment options for Oncotype DX GPS tests.
Medicare coverage for very low-, low- and all intermediate-risk patients
Your role in insurance coverage
Medicare covers the Oncotype DX Genomic Prostate Score (GPS) test for eligible patients (NCCN very low-, low-, and intermediate-risk disease). We assist your patients through the claims with their insurance company, including with your permission, help with appeals for any denial of coverage.
If your patient's insurance covers the test, our patient assistance program, Genomic Access Program (GAP) will:
Contact insurance companies on patients’ behalf.
Work with clinicians to get prior authorization from insurance companies (if required).
Bill insurance companies directly when possible.
Process the claim once the test is complete.
With your consent, assist in the appeal process if a claim is denied.
Exact Sciences offers financial assistance programs for eligible patients with financial hardship. These programs are based on financial eligibility. Learn more details by contacting Customer Service